Connect with us

Indiana

What is pentobarbital? More questions than answers surround Indiana's new execution drug. • Indiana Capital Chronicle

Published

on

What is pentobarbital? More questions than answers surround Indiana's new execution drug. • Indiana Capital Chronicle


After state officials announced last week that Indiana will resume executions for the first time in over a decade, secrecy largely shrouds the new drug, pentobarbital, acquired for the impending lethal injections.

The one-drug method is a departure from the state’s protocol used since 1995, involving a series of three chemicals.

Although no state-level executions in Indiana have used pentobarbital before, 13 federal executions carried out at the Federal Correctional Complex in Terre Haute have been carried out with the drug. Fourteen states have used pentobarbital in executions, too.

But state and federal officials alike have remained closed-lipped about where pentobarbital is sourced from and how much it costs. Also still unknown is the amount Indiana has acquired and when the current doses expire.

Advertisement

Robin Maher, executive director of the Death Penalty Information Center (DPIC), a nonprofit based in Washington, D.C. that tracks state and federal executions, said it’s also critical for the public to know who will be administering the drug — and how — as well as what training those individuals will receive. 

“These are the hard questions that have to be asked,” Maher told the Indiana Capital Chronicle. “This is an official government function, and in a democracy, we value honesty and transparency in our government officials and the acts they do on our behalf. This is absolutely one of those official acts, and voters in Indiana deserve to know what their government is doing in their name.”

What is pentobarbital?

The Hoosier state has carried out 20 executions since 1981. The first three — in 1981, 1985 and 1994 — were by electrocution. The rest have been by lethal injection — which is now the only method permitted by state law.

The Indiana Code doesn’t specify what drugs are to be used for executions, saying only that the drugs must be injected intravenously in a quantity and for an amount of time sufficient to kill the inmate.

Advertisement

Previously, when a prisoner was executed by lethal injection in Indiana, they were strapped to a gurney, and an IV line was inserted to inject a lethal combination of three substances: a barbiturate to render the person unconscious; pancuronium bromide to paralyze voluntary and reflex muscles; and potassium chloride to stop the heart.

But after Indiana’s last execution in 2009, the state was effectively forced to pause. Increased scrutiny of lethal injection drugs led pharmaceutical companies to refuse to sell their products for use in executions. Indiana Gov. Eric Holcomb said that made acquiring the necessary drugs “harder to get.”

It wasn’t until last week that the governor, along with Indiana Attorney General Todd Rokita, announced that the state’s Department of Correction has obtained the pentobarbital to carry out the death penalty.

The state is so far seeking an execution date for Joseph Corcoran, a man convicted in the killings of four people in Fort Wayne in 1997. There are currently eight men on Indiana’s death row, including Corcoran. No one has been added to the state’s death row since 2014.

In the one-drug executions, a prisoner is injected with an overdose of pentobarbital. The new drug, which Maher described as a sedative, has commonly been used to euthanize pets.

Advertisement
Joseph Corcoran killed four people in 1997 and was sentenced to death. (Mugshot)

“It’s a barbiturate that explodes the activity of the brain and the nervous system and breathing,” she said. “When you’re given an overdose of that, it will ultimately suppress breath and kill you.”

Pentobarbital was first introduced in 2010, according to the DPIC.

So far, 14 states have used the drug in executions: Alabama, Arizona, Delaware, Florida, Georgia, Idaho, Mississippi, Missouri, Ohio, Oklahoma, South Carolina, South Dakota, Texas and Virginia. Five additional states — Kentucky, Louisiana, Montana, North Carolina and Tennessee — additionally plan to use pentobarbital. Colorado includes pentobarbital as a backup drug in its lethal-injection procedure.

The same drug was also used for the 13 federal executions during the last six months of Donald Trump’s presidency.

In 2019, former U.S. Attorney General Bill Barr approved the use of pentobarbital in executions, though President Joe Biden’s ​​Justice Department announced a moratorium on federal executions in 2021.

Advertisement

A first-time method in Indiana

Whether Indiana uses pentobarbital or other drugs for executions, Maher said there are still concerns about what could go wrong.

She noted that lethal injections have the highest rate of botched executions, which occur when there is a breakdown in — or departure from — the “protocol” for a particular method of execution.

The DPIC describes at least two botched executions that have occurred in Indiana.

In October 1985, it took 17 minutes to execute William Vandiver. Still breathing after the first application of 2,300 volts, four more bursts of electricity were fired into him before he was pronounced dead, according to media reports from that time. The Indiana Department of Corrections admitted the execution “did not go according to plan.”

Tommie Smith, who died by lethal Injection in July 1996, also had a prolonged execution, according to the DPIC. Because of unusually small veins, it took more than an hour after the execution team began sticking needles into his body for Smith to be pronounced dead. After multiple attempts, the lethal drugs were finally injected into Smith 49 minutes after the process began. It took another 20 minutes before he was pronounced dead.

Advertisement

Holcomb defends Indiana’s move to carry out execution, saying ‘justice will be served’

Maher said many of the documented botched executions in recent years have occurred because the drugs being used had expired, were contaminated, or they were administered “incorrectly.” 

“There are a number of ways that the executions can go wrong, and it doesn’t only have to do with the kind of drug that is used,” she said, noting, for example, that if pentobarbital isn’t stored at a proper temperature, the drug can expire and should not be used.

When asked where DOC acquired the drug — pentobarbital, which can be used to carry out executions – and how much the state paid, Holcomb said he “can’t go into those details, by law.”

Lawmakers made information about the source of the drugs confidential on the last day of the 2017 legislative session.

Advertisement

Indiana Capital Chronicle has filed an official records request seeking the cost of the drugs.

“States have been hiding this information behind secrecy statutes in an effort to avoid answering difficult questions about their execution protocols. These are elected officials. They are using government funding, and they are saying they are conducting an official function,” Maher said. “And all of that means they should be honest and transparent about what they’re doing and why. The fact that they have shrouded everything in secrecy in an attempt to avoid answering these questions is not something that we should simply be accepting.”

Recent reporting by The Intercept and Last Week Tonight with John Oliver identified Connecticut-based Absolute Standards as the source of the pentobarbital used in 13 federal executions in 2020 and 2021. Reporting did not confirm if the company also supplied to specific states, including Indiana.

Absolute Standards produces materials for calibrating research equipment, but in 2018, it applied to the Drug Enforcement Administration to be registered as a bulk producer of pentobarbital. The company has since indicated this week that it will no longer produce the drug.

Maher further pointed to Idaho, which reportedly spent $100,000 earlier this year to purchase three doses of pentobarbital, the drug used in lethal injections. It’s not clear if that’s the same quantity purchased or price paid by Indiana, however.

Advertisement

Need to get in touch?

Have a news tip?

“What officials have said … is that they do not want to have people who are involved in the execution process — for manufacturers of a drug — to be harassed by advocates. But there are almost no real life examples of that happening unless we characterize criticism as harassment, which I don’t think we should in a democracy,” Maher said. “People who are critical of decisions the state is making, in terms of where they are finding their drugs and how they are choosing to administer them, that’s part of being a public official. Responding to those questions from your constituents — that’s part of being a public official. That comes with the territory, and there is no justifiable reason for them to avoid answering those questions.”

The Indiana Public Defender’s Office, which is providing Corcoran with legal counsel, did not reply to the Capital Chonicle’s requests for comment about pentobarbital or the impending execution.

Advertisement

Larry Komp, a federal defender for Corcoran, said the legal team is still seeking clarity on the state’s lethal injection protocol.

Groups are starting to come out against Indiana’s move, including the Libertarian Party of Indiana.

“A government whose primary function is to protect life should not be in the business of ending it, especially given the United States Constitution protects the accused from cruel and unusual punishment. There is no more cruel punishment than putting someone to death,” the party said in a statement. “The state, simply put, should not be killing its citizens. The Libertarian Party of Indiana calls upon Governor Holcomb and the State of Indiana to halt all planned executions and, furthermore, upon the General Assembly to ban the use of the death penalty in Indiana.”



Source link

Advertisement

Indiana

Op-ed: Healthy rural communities strengthen all of Indiana

Published

on

Op-ed: Healthy rural communities strengthen all of Indiana


For many Hoosiers living in rural Indiana, accessing health care can mean driving 30 minutes or even an hour to see a doctor or reach the nearest hospital. As workforce shortages and financial pressures challenge rural hospitals across the country, ensuring access to care close to home has become one of the most important health-care issues facing our state.

About one in four Indiana residents live in a rural community, yet access to health-care services in many of these communities continues to shrink. Across the nation, rural hospitals and clinics report extremely thin operating margins and often say workforce shortages and rising costs make it difficult to sustain services such as primary care, maternity care and behavioral health.

When rural communities struggle to maintain health-care access, the impact doesn’t stay confined to small towns. It ripples across the entire health-care system, contributing to increases in chronic conditions, reduced preventative care for children, and worsening outcomes for the sickest patients.

Advertisement

Communities such as Greater Lafayette serve as a regional hub for care, with hospitals like IU Health Arnett caring for patients from surrounding counties across north-central and west-central Indiana. That role is something we are proud to fulfill. But when rural residents must travel long distances for care that should be available closer to home, it places increasing pressure on emergency departments, specialty clinics and inpatient services at larger regional hospitals.

In many cases, what might have been a routine appointment, preventive screening or early diagnosis in a local clinic becomes far more serious by the time a patient reaches a larger hospital. A missed screening can escalate into a medical emergency.

That reality makes strengthening rural health care more important than ever — not just for rural communities, but for the health of the entire state.

One of the most important steps we can take is investing in the next generation of health-care professionals who will care for these communities.

Advertisement

At IU Health, we are working directly with local schools and community partners to help build that workforce pipeline. Across the region, IU Health has partnered with the Greater Lafayette Career Academy and area school districts to introduce students to health-care careers earlier and provide hands-on learning opportunities that bring those careers to life.

Through these programs, students explore health-care pathways and earn certifications such as certified nursing assistant, medical assistant or emergency medical technician while still in high school. Many participate in job shadowing opportunities, clinical experiences and mentorship programs, giving them valuable exposure to the field before they graduate. In fact, since the first cohort in 2023, IU Health has extended job offers to more than 70 students.

The goal is simple but powerful: help students see that meaningful careers in health care exist in their own communities and create pathways that allow them to stay and serve those communities.

For rural health care, this approach is critical. Students who train and develop personal mentorship connections locally are far more likely to remain in the region after completing their education. By helping young people build skills and connections early, we can create a sustainable workforce that strengthens health-care access in both rural communities and regional centers, including Greater Lafayette.

Since launching the $200 million Community Impact Investment Fund in 2018, IU Health has invested more than $40 million in community grants supporting workforce development, education and school-based programs that build Indiana’s health-care talent pipeline. This includes funding for the Indiana Latino Institute, which placed Latino students in health-care internships, supported career pathways, and provided medical interpreter training and college coaching to communities across the state.

Advertisement

Our goal is to make Indiana one of the healthiest states in the nation, and this is one way we work toward that in partnership with our communities.

But workforce development is only part of the solution.

Strengthening rural health care will also require continued collaboration between health-care providers, educators, community leaders and policymakers. Expanding telehealth access, supporting rural hospitals and investing in primary care and behavioral health services are all critical steps toward ensuring patients can receive care close to home.

Greater Lafayette will always play an important role as a regional health-care center, providing specialized care and advanced services for patients across a broad region. But the long-term health of Indiana’s health-care system depends on maintaining strong local access points for care in rural communities.

When rural clinics and hospitals can provide preventive care, manage chronic conditions and connect patients with the services they need early, the entire system works better.

Advertisement

Patients receive care sooner, communities stay healthier and larger hospitals can focus on the complex cases they are designed to treat.

Healthy rural communities do not just benefit the towns where they are. They strengthen Indiana’s entire health-care system by ensuring that every Hoosier — no matter where they live — has access to the care and resources they need to live healthier lives.

When rural health care succeeds, all of Indiana benefits.

Gary Henriott is a lifelong resident of Lafayette and the retired CEO and Chairman of Henriott Group.  He is the chair of the IU Health West Region board of directors and the Wabash Heartland Innovation Network, and president of Lafayette’s Board of Public Works and Safety. 



Source link

Advertisement
Continue Reading

Indiana

Indiana mother charged with neglect after baby’s co-sleeping death

Published

on

Indiana mother charged with neglect after baby’s co-sleeping death


INDIANAPOLIS (WKRC) — An Indianapolis mother is now facing criminal charges after her 2-month-old baby died in an apparent improper co-sleeping environment, according to investigators.

According to a probable cause affidavit obtained by FOX 59/CBS 4, police were called to an area hospital on Sept. 19, 2024, following the death of 27-year-old Brooklyn Davis’ son. The boy had been found unresponsive in his family’s home early that morning, and Davis attempted CPR before he was rushed to the hospital.

The affidavit says the boy had been sleeping on Davis’ bed with his 6-year-old brother. Davis later showed investigators a video showing the baby sleeping chest down on the 6-year-old’s chest.

An autopsy concluded the baby’s cause of death was “sudden explained death of an infant” with an intrinsic factor, which included being “placed to sleep in a queen-sized mattress being shared with a 6-year-old sibling, along with numerous blankets and other miscellaneous items; discovered unresponsive in a prone position with his face turned to the side and partially covered with a blanket.”

Advertisement

A report from the Department of Child Services (DCS) indicated the boy had no known health issues and that Davis ran an FSSA-licensed day care and has “extensive training on child care and safe sleeping environments.”

Davis had been known to DCS prior to the baby’s death. The boy had been born marijuana-positive and, on July 2, 2024, Davis had reportedly signed a “Safe Sleep Safety Plan,” acknowledging she understood that the safest places for her baby to sleep were in a crib, pack-and-play or bassinet and warned that co-sleeping places the baby at risk of suffocation and sleeping areas should be kept free of blankets, pillows and other items. The plan also included a provision that Davis not use marijuana while caring for her children, but she told investigators during an interview that, the morning of her baby’s death, she had gone downstairs to smoke marijuana and left the children alone upstairs.

Davis’ two other children were removed from the home, and interviews with them revealed that co-sleeping with the infant happened often.

Investigators say they attempted to contact Davis several times after talking to her children.

“She called me on February 18, 2025, and said she didn’t do anything wrong, her baby died of SIDS,” the detective wrote in the affidavit. “Brooklyn never came in for an additional interview.”

Advertisement

Court records indicate the case was filed in March 2026. Davis was booked into jail on April 1 on three counts of neglect of a dependent. An initial hearing was held on April 7, and a bail review hearing is planned for Monday.



Source link

Continue Reading

Indiana

Projecting the Indiana Fever’s 2026 Starting Lineup

Published

on

Projecting the Indiana Fever’s 2026 Starting Lineup


The start of training camp officially marks the beginning of the 2026 WNBA season. The Indiana Fever were fairly quiet during free agency after successfully retaining most of their top-tier talent such as Kelsey Mitchell, Aliyah Boston, Lexie Hull, and Sophie Cunningham. Though they still managed to add a few solid pieces to further stack their depth.

Advertisement

Last season the Fever made an impressive postseason run despite facing multiple injuries, particularly in the backcourt. The front office clearly prioritized guard depth as a result, as well as looking to upgrade at the power forward position.

Advertisement

The Fever brass aimed to shore up any defensive deficiencies on the perimeter in the draft by adding guard Raven Johnson out of South Carolina, who brings a reputation as a defensive stopper. As for bolstering the frontcourt, to play alongside, and even provide some relief for Aliyah Boston, newly acquired 6-foot-4 Monique Billings and veteran forward Myisha Hines-Allen fit the bill. Indiana also picked up another solid player in Tyasha Harris at the guard position to provide backcourt depth and relieve pressure on Kelsey Mitchell and Caitlin Clark.

As for the starting lineup, here’s who the Indiana Fever are projected to run with:

Advertisement

Caitlin Clark, Guard

Jun 17, 2025; Indianapolis, Indiana, USA; Indiana Fever guard Caitlin Clark (22) shoots the ball in the first half against the Connecticut Sun at Gainbridge Fieldhouse. Mandatory Credit: Trevor Ruszkowski-Imagn Images | Trevor Ruszkowski-Imagn Images

This comes as no surprise, but Clark will look to lead the way for the Fever in one of the two starting guard roles. Coming off of a season riddled with injuries, her return is highly anticipated. In true Clark fashion, she showed positive signs of production during the FIBA World Cup qualifiers where she led Team USA in assists and points.

Clark is expected to return to form in 2026. She provides speed in transition, is a deep threat from beyond the arc, and is elite at setting up her teammates. The only thing standing in the way of a productive season for Clark is remaining healthy for the duration of the season.

Advertisement

Kelsey Mitchell, Guard

Sep 30, 2025; Las Vegas, Nevada, USA; Indiana Fever guard Kelsey Mitchell (0) dribbles against the Las Vegas Aces during the first quarter of game five of the second round of the 2025 WNBA Playoffs at Michelob Ultra Arena. Mandatory Credit: Stephen R. Sylvanie-Imagn Images | Stephen R. Sylvanie-Imagn Images
Advertisement

Re-signing Kelsey Mitchell was yet again the main offseason priority for the Fever and they did just that. Coming off of a career year, Mitchell will be a key component in the Fever reaching a championship. She averaged 20.2 points per game last season and carried the team on her back during Clark’s absence.

Advertisement

As a premier scoring guard, she complements Clark’s game well and when the two are on the floor together, they’re easily the most explosive backcourt in the entire WNBA. Mitchell has exceptional speed and is a gifted isolation scorer. Her ability to quickly cut and drive to the rim makes her a nightmare for opposing teams to defend and contributed to her earning a 2025 All-WNBA First Team selection.

Mitchell is one of the most dangerous clutch situation players in the league making her a stellar weapon for the Fever.

Advertisement

Lexie Hull, Forward

Aug 17, 2025; Uncasville, Connecticut, USA; Indiana Fever guard Lexie Hull (10) reacts after her three point basket against the Connecticut Sun in overtime at Mohegan Sun Arena. Mandatory Credit: David Butler II-Imagn Images | David Butler II-Imagn Images

Entering her fifth WNBA season, all with the Fever, no other player on the roster has grown as much as Lexie Hull. Her steady development has made her a key piece and earned her a starting role in the rotation as last season progressed. Listed as a guard, her defense and versatility has allowed her to frequently fill the role of small forward. She impacts the game on both ends of the floor and saw career highs in 2025 in points per game (7.2), rebounds per game (4.3), assists per game (1.8) and steals per game (1.2).

Her impactful instincts even contributed to her being near the top of the WNBA in offensive fouls drawn last season. With her high-percentage shooting from beyond the arc, solid perimeter defense, and elite hustle, Hull fills the wing role nicely for the Fever.

Advertisement

Monique Billings, Forward

Sep 17, 2025; San Jose, California, USA; Golden State Valkyries forward Monique Billings (25) boxes out Minnesota Lynx forward Alanna Smith (8) in the fourth quarter in game two of round one for the 2025 WNBA Playoffs at SAP Center. Mandatory Credit: David Gonzales-Imagn Images | David Gonzales-Imagn Images
Advertisement

Heading into the 2026 season, the Fever desperately needed to add talented size up front to complement Aliyah Boston’s skill set. With the departure of veteran Natasha Howard in free agency, the Fever acquired their likely next starting power forward in Monique Billings.

Advertisement

Billings is a strong finisher around the basket, has soft hands, runs the floor well, and is adept at screening for guards. She can also defend multiple positions and is a more than capable rebounder. Billings checks all of the boxes of a needed component for Indiana.

Aliyah Boston, Center

Advertisement

Las Vegas Aces center A’ja Wilson (22) defends Indiana Fever forward Aliyah Boston (7) during Game 4 of the WNBA semifinals on Sunday, Sept. 28, 2025, at Gainbridge Fieldhouse in Indianapolis. The Fever defeated the Aces 90-83. | Christine Tannous/IndyStar / USA TODAY NETWORK via Imagn Images

After making WNBA history with a record contract, Aliyah Boston looks to continue to elevate her game. Boston has quickly ascended as one of the league’s biggest threats in the middle of the floor. What makes this season even more promising for Boston is the dominant performances she put on display during Unrivaled.

She’s in peak physical shape, faster and has worked on her three-point shooting – an area she committed herself to improving on in the offseason. The three-time All-Star has already established herself as a force on the block due to her combination of size and footwork. Her step-through moves have increased her efficiency in scoring under the basket.

Boston seems poised to have the best season of her career in 2026.

Advertisement

Add us as a preferred source on Google



Source link

Continue Reading
Advertisement

Trending